1.19
price down icon4.03%   -0.05
pre-market  プレマーケット:  1.15   -0.04   -3.36%
loading
前日終値:
$1.24
開ける:
$1.18
24時間の取引高:
859.00K
Relative Volume:
0.73
時価総額:
$60.38M
収益:
-
当期純損益:
$-67.68M
株価収益率:
-0.7169
EPS:
-1.66
ネットキャッシュフロー:
$-54.24M
1週間 パフォーマンス:
-26.09%
1か月 パフォーマンス:
-28.74%
6か月 パフォーマンス:
-72.39%
1年 パフォーマンス:
-92.76%
1日の値動き範囲:
Value
$1.14
$1.23
1週間の範囲:
Value
$1.14
$1.615
52週間の値動き範囲:
Value
$1.14
$19.04

Cabaletta Bio Inc Stock (CABA) Company Profile

Name
名前
Cabaletta Bio Inc
Name
セクター
Healthcare (1163)
Name
電話
(267) 759-3100
Name
住所
2929 ARCH STREET, PHILADELPHIA, PA
Name
職員
154
Name
Twitter
@CabalettaBio
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
CABA's Discussions on Twitter

CABA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CABA
Cabaletta Bio Inc
1.19 60.38M 0 -67.68M -54.24M -1.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 66.76B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-20 ダウングレード Evercore ISI Outperform → In-line
2024-12-19 ダウングレード Wells Fargo Overweight → Equal Weight
2024-10-10 開始されました UBS Buy
2024-02-05 開始されました Jefferies Buy
2023-11-29 開始されました William Blair Outperform
2023-10-24 開始されました Cantor Fitzgerald Overweight
2023-10-19 開始されました Stifel Buy
2023-09-05 開始されました Citigroup Buy
2023-07-18 開始されました Guggenheim Buy
2023-01-27 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-08-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-12-08 開始されました Wells Fargo Overweight
2021-10-19 再開されました Morgan Stanley Overweight
2021-06-30 開始されました Mizuho Buy
2021-01-08 開始されました Chardan Capital Markets Buy
2020-10-13 開始されました H.C. Wainwright Buy
2019-11-19 開始されました Cowen Outperform
2019-11-19 開始されました Evercore ISI Outperform
2019-11-19 開始されました Morgan Stanley Overweight
すべてを表示

Cabaletta Bio Inc (CABA) 最新ニュース

pulisher
04:18 AM

Analysts Offer Predictions for Cabaletta Bio FY2029 Earnings - Defense World

04:18 AM
pulisher
02:27 AM

FY2025 EPS Forecast for Cabaletta Bio Raised by Analyst - Defense World

02:27 AM
pulisher
Apr 03, 2025

Wells Fargo & Company Lowers Cabaletta Bio (NASDAQ:CABA) Price Target to $3.00 - MarketBeat

Apr 03, 2025
pulisher
Apr 03, 2025

Kaskela Law LLC Announces Stockholder Investigation of Cabaletta Bio, Inc.CABA - ACCESS Newswire

Apr 03, 2025
pulisher
Apr 03, 2025

Cabaletta Bio stock hits 52-week low at $1.15 amid sharp decline - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Recommendation of “Buy” by Analysts - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Cabaletta Bio (NASDAQ:CABA) Receives Buy Rating from Guggenheim - MarketBeat

Apr 02, 2025
pulisher
Apr 02, 2025

Cabaletta Bio (NASDAQ:CABA) Price Target Cut to $22.00 by Analysts at Morgan Stanley - MarketBeat

Apr 02, 2025
pulisher
Apr 02, 2025

Cabaletta Bio (NASDAQ:CABA) Posts Earnings Results, Meets Expectations - MarketBeat

Apr 02, 2025
pulisher
Apr 02, 2025

Cabaletta Bio's (CABA) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Apr 02, 2025
pulisher
Apr 02, 2025

Cabaletta Bio (NASDAQ:CABA) Releases Earnings Results, Meets Estimates - MarketBeat

Apr 02, 2025
pulisher
Apr 02, 2025

Cabaletta Bio Reports Strong Clinical Progress and Q4 2024 Financial Results - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Charles Schwab Investment Management Inc. Sells 16,585 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Cabaletta Bio (NASDAQ:CABA) Receives Buy Rating from HC Wainwright - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Cabaletta Bio’s (CABA) “Buy” Rating Reaffirmed at Guggenheim - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Cabaletta Bio (NASDAQ:CABA) Given New $3.00 Price Target at Wells Fargo & Company - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Cabaletta Bio Advances T Cell Therapies for Autoimmune Diseases - TipRanks

Apr 02, 2025
pulisher
Apr 01, 2025

UBS cuts Cabaletta Bio stock target to $7, maintains Buy rating - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Cabaletta Bio’s Strategic Advances in Myositis Treatment Drive Buy Rating - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

UBS cuts Cabaletta Bio stock target to $7, maintains Buy rating By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Is Cabaletta Bio Inc (CABA) worth investing in despite its undervalued state? - uspostnews.com

Apr 01, 2025
pulisher
Apr 01, 2025

UBS Adjusts Price Target on Cabaletta Bio to $7 From $10, Keeps Buy Rating - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Cabaletta Bio price target lowered to $22 from $30 at Morgan Stanley - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Stifel cuts Cabaletta Bio stock target to $13, maintains buy By Investing.com - Investing.com Canada

Apr 01, 2025
pulisher
Mar 31, 2025

Stifel cuts Cabaletta Bio stock target to $13, maintains buy - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

BIT Capital GmbH Invests $431,000 in Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

Cabaletta Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Cabaletta Bio, Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Cabaletta Bio Reports Clinical Wins in Multiple Diseases, Maintains Strong Cash Position - Stock Titan

Mar 31, 2025
pulisher
Mar 29, 2025

Bank of New York Mellon Corp Sells 16,945 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

Mar 29, 2025
pulisher
Mar 26, 2025

Cabaletta Bio stock hits 52-week low at $1.59 amid sharp decline By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Cabaletta Bio stock hits 52-week low at $1.59 amid sharp decline - Investing.com Australia

Mar 26, 2025
pulisher
Mar 24, 2025

Are Value Hunters Buying Cabaletta Bio Inc (NASDAQ: CABA) Stock? - Stocks Register

Mar 24, 2025
pulisher
Mar 22, 2025

Head-To-Head Comparison: Cabaletta Bio (NASDAQ:CABA) vs. Outlook Therapeutics (NASDAQ:OTLK) - Defense World

Mar 22, 2025
pulisher
Mar 22, 2025

Cabaletta Bio (CABA) Projected to Post Earnings on Thursday - MarketBeat

Mar 22, 2025
pulisher
Mar 20, 2025

Cellares and Cabaletta Bio Complete Manufacturing Technology Adoption Program - Genetic Engineering and Biotechnology News

Mar 20, 2025
pulisher
Mar 19, 2025

Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle™ Platform - Business Wire

Mar 19, 2025
pulisher
Mar 19, 2025

Major Breakthrough: Cellares Successfully Automates Multi-Batch CAR T Production for 260,000 Patients - Stock Titan

Mar 19, 2025
pulisher
Mar 17, 2025

Cabaletta Bio Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView

Mar 17, 2025
pulisher
Mar 16, 2025

Cabaletta Bio (CABA) to Release Quarterly Earnings on Thursday - MarketBeat

Mar 16, 2025
pulisher
Mar 16, 2025

Analysts Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $22.71 - MarketBeat

Mar 16, 2025
pulisher
Mar 12, 2025

Brokerages Set Cabaletta Bio, Inc. (NASDAQ:CABA) Target Price at $22.71 - MarketBeat

Mar 12, 2025
pulisher
Mar 09, 2025

Cabaletta Bio, Inc. (NASDAQ:CABA) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Mar 09, 2025
pulisher
Mar 06, 2025

Head-To-Head Contrast: Cabaletta Bio (NASDAQ:CABA) & Cidara Therapeutics (NASDAQ:CDTX) - Defense World

Mar 06, 2025
pulisher
Mar 02, 2025

Cabaletta Bio to Present at TD Cowen 45th Annual Health Care Conference - MSN

Mar 02, 2025

Cabaletta Bio Inc (CABA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
大文字化:     |  ボリューム (24 時間):